Targeted therapies for the treatment of cancer

This publication has 25 references indexed in Scilit:

• Weekly administration of paclitaxel: theoretical and clinical basis
  Critical Reviews in Oncology/Hematology, 2002
• Part I: Chemotherapy for epithelial ovarian cancer–treatment at first diagnosis
  The Lancet Oncology, 2002
• The chimeric anti-CD20 antibody rituximab induces apoptosis in B-cell chronic lymphocytic leukemia cells through a p38 mitogen activated protein–kinase–dependent mechanism
  Blood, 2002
• Radiation-induced DNA Damage and Chromatin Structure
  Acta Oncologica, 2001
• Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.
  Journal of Clinical Oncology, 1998
• Apoptosis of Malignant Human B Cells by Ligation of CD20 With Monoclonal Antibodies
  Blood, 1998
• Humanized Antibodies: Enhancing Therapeutic Utility Through Antibody Engineering
  International Reviews of Immunology, 1993
• Accomplishments in surgical adjuvant therapy for large bowel cancer
  Cancer, 1992
• The structure and function of the epidermal growth factor receptor studied by using antisynthetic peptide antibodies
  Proceedings of the Royal Society of London. B. Biological Sciences, 1985
• Derivation of specific antibody‐producing tissue culture and tumor lines by cell fusion
  European Journal of Immunology, 1976